- Home
- PLRX vs NDMO Comparison
PLRX vs NDMO Comparison
Compare PLRX & NDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- NDMO
- Stock Information
- Founded
- PLRX 2015
- NDMO 2019
- Country
- PLRX United States
- NDMO United States
- Employees
- PLRX N/A
- NDMO N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- NDMO Trusts Except Educational Religious and Charitable
- Sector
- PLRX Health Care
- NDMO Finance
- Exchange
- PLRX Nasdaq
- NDMO Nasdaq
- Market Cap
- PLRX 77.3M
- NDMO N/A
- IPO Year
- PLRX 2020
- NDMO N/A
- Fundamental
- Price
- PLRX $1.40
- NDMO $10.12
- Analyst Decision
- PLRX Hold
- NDMO
- Analyst Count
- PLRX 10
- NDMO 0
- Target Price
- PLRX $9.79
- NDMO N/A
- AVG Volume (30 Days)
- PLRX 1.6M
- NDMO 218.6K
- Earning Date
- PLRX 08-06-2025
- NDMO 01-01-0001
- Dividend Yield
- PLRX N/A
- NDMO 6.75%
- EPS Growth
- PLRX N/A
- NDMO N/A
- EPS
- PLRX N/A
- NDMO N/A
- Revenue
- PLRX N/A
- NDMO N/A
- Revenue This Year
- PLRX N/A
- NDMO N/A
- Revenue Next Year
- PLRX N/A
- NDMO N/A
- P/E Ratio
- PLRX N/A
- NDMO N/A
- Revenue Growth
- PLRX N/A
- NDMO N/A
- 52 Week Low
- PLRX $1.10
- NDMO $8.99
- 52 Week High
- PLRX $16.10
- NDMO $11.24
- Technical
- Relative Strength Index (RSI)
- PLRX 54.68
- NDMO 52.87
- Support Level
- PLRX $1.13
- NDMO $9.95
- Resistance Level
- PLRX $1.27
- NDMO $10.20
- Average True Range (ATR)
- PLRX 0.11
- NDMO 0.11
- MACD
- PLRX 0.02
- NDMO 0.00
- Stochastic Oscillator
- PLRX 90.00
- NDMO 51.52
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.